Cipla Limited
$18.68
24H
Market Cap
Volume
Supply
Price Chart
About Cipla Limited - CIPLA.NS
Cipla Ltd is a global pharmaceutical company based in India, known for manufacturing a range of medicinal products including prescription drugs, over-the-counter medication, and veterinary products, particularly famous for its contributions to the production of low-cost anti-retroviral drugs for HIV/AIDS. The company also engages in active pharmaceutical ingredients (APIs) manufacturing and has a presence in several other countries through subsidiaries and partnerships.
What are Cipla Limited's core values and mission statement?
CIPLA LTD's core values focus on deep care for patients' needs, fostering innovation, pursuing excellence, and ensuring accessibility of essential medication. Their mission statement centers on making high-quality pharmaceuticals affordable and accessible to all, particularly in underserved markets.
Who founded Cipla Limited and when?
CIPLA Ltd was founded by Dr. Khwaja Abdul Hamied in 1935.
Who leads Cipla Limited?
Cipla Ltd is led by Umang Vohra, who holds the position of Managing Director and Global CEO.
Where is Cipla Limited located, and what is its base country?
Cipla Ltd is headquartered in Mumbai, India, and its base country is India.
On which exchanges is Cipla Limited traded?
CIPLA LTD is primarily traded on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) in India.
Historical data
Cipla Limited (CIPLA) Price Live Data
The live price of Cipla Limited (CIPLA) is $18.68, with a trading volume of 1,566,575 in the last 24 hours. Wrapstocks updates the CIPLA price in real-time. Cipla Limited is down -2.43% in the last 24 hours. The company has a live market cap of $15,084,646,044.79 and a supply of 807,594,989 CIPLA stocks.
Cipla Limited (CIPLA) is traded on India National Stock Exchange, and currently, the market is closed; trading will be resumed in 15 hours and 34 minutes.
